There are a number of conditions that must be met in order to treat prostate cancer through surgery, taking into account the patient’s tumor stage (which is related to the effectiveness of the surgery, for example, if the patient has advanced metastasis, there is not much point in having surgery to remove the tumor completely), general health status (whether the patient can tolerate the blow to the body from surgery), life expectancy (if the patient is too old and life expectancy is too short, the blow from surgery may outweigh the benefit), and many other factors. (if the patient is too old and the life expectancy is too short, the blow of surgery may outweigh the benefit) and many other factors. Therefore, patients with prostate cancer should be considered for surgery only if they meet all of the following conditions: 1) patients with limited prostate cancer, tumor stage T1-T2c; 2) patients with life expectancy greater than or equal to 10 years; 3) patients should be in good health, free of serious cardiopulmonary disease, and able to tolerate surgery. For patients with local tumor stage T2, combined with local lymph node metastasis (T1) without distant metastasis, the treatment plan is still controversial in clinical practice. Although the number of such patients is relatively small, most scholars at home and abroad still believe that radical prostatectomy with local lymph node dissection should be actively performed for such patients, after which endocrine therapy or radiotherapy should be added according to the lymph node metastasis and the local condition of the prostate.